Eligibility in the Clean Technology category requires applicants to meet the same criteria as Technology Fast 50 nominees except they must have a minimum revenue of $50,000 in 2020 and $5 million in ...

MEDFAR, developer of the Integrated Care Platform MYLE and leading Canadian EMR provider, is proud to announce it ranked 47th on the Deloitte Technology Fast 50 list in Canada, thanks to 423% revenue ...

In this interview, Simon Quick, CEO of (CSE: CCI), provides insights into the company’s transformative acquisition of the Caribou processing plant complex and their path ...

MONTREAL, Nov. 06, 2024 (GLOBE NEWSWIRE) -- BrainBox AI, a pioneer in autonomous and generative AI building technology, today announced it is the recipient of the Companies-to-Watch award in the 2024 ...

Propel Holdings Inc. ("Propel" or the "Company") (TSX: PRL) was honored as an Enterprise—Industry Leaders award winner as part of Deloitte's 2024 Technology Fast 50™ program. The award recognizes the ...

Lightspeed logo (CNW Group/Lightspeed Commerce Inc.) The award recognizes the fastest-growing enterprise-level technology, media, and telecommunications companies by revenue growth percentage over ...

Immigrants help grow Canada’s future. According to Statistics Canada, immigrants are making important contribution across every sector of Canada’s economy. As of May 2021, immigrants aged 25 to 54 ...

His assignment was to help determine the boundary between Canada and the United States in order to clarify a treaty signed by Russia and Great Britain in 1825. While atop the mountain, he turned ...

With only days left before their November 1 release, T-Series, the producers of Bhool Bhulaiyaa 3, have reached out to the Competition Commission of India (CCI), accusing the makers of Singham Again ...

This merger creates India's largest media conglomerate valued at Rs 70,000 crore. CCI had previously announced its approval of the merger on August 28, which would result in the creation of India ...

SAN DIEGO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development ...